IL4 and neoplasm: (1) IL-10, RANTES, Eotaxin, MCP-1, IL-13, MIG, IL-8, and IL-1β presented a progressively increasing trend in the peripheral blood (Figure 6A); (2) IFN-α IL-6, and IL-2 declined from healthy to inflammation or tumor, while TNF-α showed a decreased trend in the inflammation group (Figure 6B); (3) IL-12, IL-17, GM-CSF, MIP-1α, IL-5, IFN-γ, IL-1r, IL-7, IP-10, IL-2r, IL-4, IL-15, and MIP-1β showed a slight increase in the inflammatory group (Figure 6C).